Thus, several studies focused on the development of an NAFLD risk prediction model based on biochemical indicators including high-density lipoprotein cholesterol (HDL-c), total cholesterol, alanine aminotransferase (ALT), metabolic disorders like obesity and T2DM, and lifestyle features such as dietary habits and physical activity. The gene discussed is GPT; the disease is metabolic disease.